Clinical Trial Update: Cardiac Resynchronization Therapy, Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure (CHF) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating cardiac resynchronization therapy to improve dyspnea and exercise tolerance in congestive heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Queen's University | Conditions: Congestive Heart Failure | Phase 4 | Status: TERMINATED